MAINZ, Germany—The chief executive of the German company partnering with Pfizer Inc. in its coronavirus vaccine effort said the two are racing to increase production to meet the world’s needs, assuming the shot wins a regulatory green light. The two companies are now scrambling to scale up their manufacturing capacities, said Ugur Sahin, CEO of BioNTech SE. Both companies said they are confident they will be able to deliver all the doses they have already agreed to provide to governments, including the U.S. and the European...

Source: Wall Street Journal October 15, 2020 20:06 UTC